Table 1.

Lead variants for the genome-wide associated loci in the attention domain.

	Chr: Pos	Effect allele (freq)	Intercept		Baseline age		Slope 1		Slope 2		Prioritised Gene	V2G evidence
rsID			beta	P	beta	P	beta	P	beta	P
rs534221751	21: 23,327,457	A (0.108)	−0.13	0.01	0.01	0.33	1.30	1.1e−08	−0.22	0.07	–	–
rs34743896	2: 46,264,984	T (0.072)	−0.01	0.73	0.002	0.72	0.54	0.03	−0.82	4.7e−10	EPAS1	Distance

Chr:Pos are according to build 38. Prioritised genes are the top genes listed by Open Targets Genetics [38, 39] and the evidence used in this assessment are listed in the V2G (variant to the gene) evidence column.

Associations with p < 5 × 10⁻⁸ are marked in bold.